Floatz logo

Hepabulin

Hepatitis B Virus Infection

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)other_biologicalUnknownDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Hepatitis B Virus Infection cohort.

Asset / SponsorPhaseRating
Entecavir
Sun Yat-sen University
Phase 4BBB
Lamivudine
Fudan University
Phase 4BBB
Tenofovir
Ruijin Hospital
Phase 4BB
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Tenofovir Bis(Isopropyloxycarbonyloxymethyl) Ester
West China Hospital
Phase 4BB

View all 42 →

Same molecule, other indications

Hepabulin is also rated in:

cirrhosis of liverDormant
D
Indicative · Unknown
30 / 100
View asset →
acute liver failureDormant
D
Indicative · Unknown
30 / 100
View asset →
hepatocellular carcinomaDormant
D
Indicative · Unknown
28 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →